MedTrace Logo

Human Papilloma Virus DNA Self-Test

NCT00266266 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 171

Last updated 2017-12-29

No results posted yet for this study

Summary

HPV DNA testing by a clinician has been shown to be highly sensitive in detecting cervical disease. Can we prove that HPV self-testing will be sufficiently sensitive to detect disease in high risk population who for various reasons would not have routine pap smear screening?

Conditions

  • Papilloma Virus, Human

Sponsors & Collaborators

  • James Graham Brown Cancer Center

    collaborator OTHER

  • University of Louisville

    lead OTHER

Principal Investigators

  • Robert Edwards, MD · University of Louisville,James Graham Brown Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00266266 on ClinicalTrials.gov